New Short Bowel Syndrome Study Launched By Major Health Company

A Breakthrough for Short Bowel Syndrome Patients: Napo Pharmaceuticals Launches New Study.

Disclaimer: The content provided is for informational purposes only, aiming to educate and inform readers about recent developments in medical research. It does not constitute medical advice.

In an exciting development for individuals living with Short Bowel Syndrome (SBS), Napo Pharmaceuticals, a subsidiary of Jaguar Health, Inc., has initiated a ground…